A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non–small cell lung cancer

R Mutter, B Lu, DP Carbone, I Csiki, L Moretti… - Clinical Cancer …, 2009 - AACR
Abstract Purpose: Cyclooxygenase (COX)-2 up-regulation plays an important role in the
pathogenesis of lung cancer. Selective COX-2 inhibitors have promoted chemosensitivity …
被引用次数：107 相关文章

A Phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer

R Mutter, B Lu, DP Carbone, I Csiki… - Clinical Cancer …, 2009 - ohiostate.elsevierpure.com
Purpose: Cyclooxygenase (COX)-2 up-regulation plays an important role in the
pathogenesis of lung cancer. Selective COX-2 inhibitors have promoted chemosensitivity …

A Phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer

R Mutter, B Lu, DP Carbone, I Csiki… - Clinical Cancer …, 2009 - researchoutput.ncku.edu.tw
Purpose: Cyclooxygenase (COX)-2 up-regulation plays an important role in the
pathogenesis of lung cancer. Selective COX-2 inhibitors have promoted chemosensitivity …

A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer

R Mutter, B Lu, DP Carbone, I Csiki… - … : an official journal …, 2009 - pubmed.ncbi.nlm.nih.gov
Purpose Cyclooxygenase (COX)-2 up-regulation plays an important role in the
pathogenesis of lung cancer. Selective COX-2 inhibitors have promoted chemosensitivity …

[引用][C] A Phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer

R Mutter, B Lu, DP Carbone, I Csiki… - Clinical cancer …, 2009 - difusion.ulb.ac.be

A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer.

R Mutter, B Lu, DP Carbone, I Csiki… - … Cancer Research: an …, 2009 - europepmc.org
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for
patients with inoperable stage IIIA/B non-small cell lung cancer. - Abstract - Europe PMC Sign …

A Phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer

R Mutter, B Lu, DP Carbone, I Csiki… - Clinical Cancer …, 2009 - mayoclinic.elsevierpure.com
Purpose: Cyclooxygenase (COX)-2 up-regulation plays an important role in the
pathogenesis of lung cancer. Selective COX-2 inhibitors have promoted chemosensitivity …

[引用][C] A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer

R MUTTER - Clin Cancer Res, 2009 - cir.nii.ac.jp
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for
patients with inoperable stage IIIA/B non-small cell lung cancer | CiNii Research CiNii 国立 …

A Phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer

R Mutter, B Lu, DP Carbone… - Clinical Cancer …, 2009 - utsouthwestern.elsevierpure.com
Purpose: Cyclooxygenase (COX)-2 up-regulation plays an important role in the
pathogenesis of lung cancer. Selective COX-2 inhibitors have promoted chemosensitivity …

[引用][C] A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non-Small Cell Lung …

R MUTTER, BO LU, H CHOY… - Clinical cancer …, 2009 - pascal-francis.inist.fr
A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy
for Patients with Inoperable Stage IIIA/B Non - Small Cell Lung Cancer CNRS Inist …